Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 20
- Clinical Research
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
- US & Canada
How New York’s Next Mayor Will Shape the Future of Cannabis in the State
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the state’s vast but unsettled cannabis market has become a key battleground for the three hopefuls.
- US & Canada
Countdown to Business of Cannabis: New York 2025, Celebrating Our Pioneering Sponsors
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300 leaders from across the cannabis ecosystem for a day of strategic dialogue, networking, and market insight.
- Clinical Research
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
- International Regulation
Drug War 2.0 Puts International Cannabis Reform at Risk
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy, a combination that threatens to reshape the outlook for cannabis reform and regulation This morning, news broke that the US military had carried out another series of airstrikes on alleged drug traffickers in the Eastern…
- Prescribers & Clinics
Airo Brands Announces CE-Certified Medical Inhalation Device in Partnership with SOMAÍ
Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received regulatory approval for its CE-marked Class IIa medical handheld liquid inhalation device, the Airo Medical Inhalation System, across Europe and Australia.
- Industry Trends
New York Cannabis Retailers Push Back on $30m Product Recall and ‘Rent-a-Licence’ Scandal
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal.
- Medical Cannabis
Germany Expands Its Medical Cannabis Import Cap as Australia Moves to Cut Back
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets.
- Industry Trends
Early Results From Züri Can Pilot Bolster Case for Switzerland’s Federal Legalisation
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption.
- Medical Cannabis
ACCM Launches National Partnerships to Expand Medical Cannabis Access and Insurance Coverage
The American Council of Cannabis Medicine (ACCM) has announced the launch of a new nationwide initiative with major insurers, healthcare systems, and associations to expand affordable access to medically guided cannabis treatment across the United States.
- Public Markets
Synbiotic Downgrade Signals German Market Slowdown, Chill Brands Pivots to Wholesale as Wellnex Exits Cannabis
Synbiotic SE German cannabis and hemp group Synbiotic SE has issued a substantial downgrade to both its sales and profit forecasts for the full year 2025 as Germany’s rapidly inflated medical cannabis bubble shows the first signs it could be about to burst.
- Press releases
Curaleaf Laboratories Backs UK Cannabis Health Symposium with MCCS
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025 at Conway Hall, London.
